The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis

LL O'Mahoney, A Routen, C Gillies, W Ekezie… - …, 2023 - thelancet.com
Background The aim of this study was to systematically synthesise the global evidence on
the prevalence of persistent symptoms in a general post COVID-19 population. Methods A …

Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation

SJ Singh, MM Baldwin, E Daynes, RA Evans… - The Lancet …, 2023 - thelancet.com
Although the exact prevalence of post-COVID-19 condition (also known as long COVID) is
unknown, more than a third of patients with COVID-19 develop symptoms that persist for …

A multi-center study investigating long COVID-19 in healthcare workers from North-Eastern Italy: prevalence, risk factors and the impact of pre-existing humoral …

L Cegolon, M Mauro, D Sansone, A Tassinari… - Vaccines, 2023 - mdpi.com
Introduction: The impact of long-COVID-19 syndrome is rather variable, since it is influenced
by several residual confounders. This study aimed to investigate the prevalence of long …

Pulmonary recovery 12 months after non-severe and severe COVID-19: the prospective swiss COVID-19 lung study

A Lenoir, A Christe, L Ebner, C Beigelman-Aubry… - Respiration, 2023 - karger.com
Background: Lung function impairment persists in some patients for months after acute
coronavirus disease 2019 (COVID-19). Long-term lung function, radiological features, and …

Post-COVID-19 respiratory problems: burden and management

A Kessler, M Heightman, E Brennan - Current Opinion in …, 2022 - journals.lww.com
The vast numbers of COVID-19 infections globally implies that a large number of people will
be affected by post-COVID sequelae even with conservative estimates. A significant number …

Impact of COVID infection on lung function test and quality of life

MR Toh, YR Teo, LCR Poh, Y Tang, RY Soh… - Scientific Reports, 2023 - nature.com
Post-COVID-19 pulmonary sequalae are well-recognized early in the pandemic.
Survivorship clinics are crucial for managing at-risk patients. However, it is unclear who …

Lung Function Trajectories in Mild COVID-19 With 2-year Follow-up

KK Iversen, A Ronit, MG Ahlström… - The Journal of …, 2024 - academic.oup.com
Background The long-term pulmonary sequelae of mild coronavirus disease 2019 (COVID-
19) remains unknown. In this study, we aimed to characterize lung function trajectories in …

COVID-19 and interstitial lung diseases: A multifaceted look at the relationship between the two diseases

J Fukihara, Y Kondoh - Respiratory Investigation, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although it has been a fatal …

The alveolar fibroproliferative response in moderate to severe COVID-19-related acute respiratory distress syndrome and 1-yr follow-up

S Zhang, LS Boers, J de Brabander… - … of Physiology-Lung …, 2024 - journals.physiology.org
COVID-19-related acute respiratory distress syndrome (ARDS) can lead to long-term
pulmonary fibrotic lesions. Alveolar fibroproliferative response (FPR) is a key factor in the …

Long COVID: The long-term consequences of COVID-19 and the proposed pathophysiological mechanisms

M Masood, SS Chodisetti… - Journal of Nature and …, 2023 - journals.lww.com
The new devastating pandemic coronavirus disease 2019 (COVID-19) caused by the novel
coronavirus severe acute respiratory syndrome (SARS-CoV-2) has been related to …